ALKEON CAPITAL MANAGEMENT LLC

Q3 2023 13F-HR Detailed Holdings

Location
New York, NY
Holdings as of
9/30/2023
Date filed
11/14/2023
Form type
13F-HR
Num holdings
205
Total value ($000)
$55,912,333
Net value change ($000)
-1,254,201 (-2.2%)
New positions
4
Sold out positions
14
Turnover %
7.8%
Sector allocation + QoQ delta (equities-only)

Holdings broken out by other managers reported in the original SEC filing. View aggregated holdings

You are on the SEC detailed breakdown page. Rows are shown as reported in the filing (including other manager, discretion, and voting authority fields), and are not merged like the standard holdings view. Switch to aggregated holdings.

Snapshot: Change Analysis

Compared to Q2 2023
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
DELL 226,815 335.3%
KLAC 163,512 44.5%
ADBE 152,970 NEW
DDOG 127,526 NEW
AMZN 119,664 16.7%
GOOGL 117,365 10.2%
META 109,498 6.3%
WDAY 107,425 NEW
MRVL 102,847 NEW
ESTC 91,879 130.7%
Top Reduces (Value $000, Stocks/ETFs)
MSFT -220,179 -34.5%
BABA -190,743 -57.1%
QQQ -157,004 -100.0%
BILL -146,099 -100.0%
SNPS -129,872 -23.5%
SHOP -117,938 -100.0%
CDNS -113,883 -22.9%
QCOM -105,560 -39.7%
PDD -104,625 -100.0%
TSM -84,070 -13.9%
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000): 40,112,694 (71.7% of total reported value)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type Discretion Other Manager Sole Shared None

Other Managers

Num Name File Number
1 OPPENHEIMER ASSET MANAGEMENT INC. 028-10748